VKH
NWBO

Virtu KCG Holdings’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Virtu KCG Holdings’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-80,918
Closed -$44K – 4206
2016
Q3 		$44K Buy
80,918
+48,228
+148% +$22.1K ﹤0.01% 2814
2016
Q2 		$19K Buy
32,690
+17,861
+120% +$19.1K ﹤0.01% 2805
2016
Q1 		$22K Sell
14,829
-30,724
-67% -$60.6K ﹤0.01% 2588
2015
Q4 		$146K Buy
+45,553
New +$219K ﹤0.01% 2871
2015
Q3 		– Sell
-32,208
Closed -$320K – 4338
2015
Q2 		$320K Buy
32,208
+15,800
+96% +$138K 0.01% 1988
2015
Q1 		$121K Buy
16,408
+2,057
+14% +$13.8K ﹤0.01% 2600
2014
Q4 		$77K Sell
14,351
-17,489
-55% -$89.5K ﹤0.01% 3318
2014
Q3 		$160K Buy
31,840
+476
+2% +$2.92K ﹤0.01% 3044
2014
Q2 		$211K Buy
+31,364
New +$200K ﹤0.01% 3007

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Virtu KCG Holdings's NWBO Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 80,918 shares — an estimated $44K sold.

Virtu KCG Holdings first reported a position in NWBO in Q2 2014 and held it in 9 quarters. The position peaked at $320K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 80,918 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $44K.
  • Virtu KCG Holdings first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 9 quarters.
  • Virtu KCG Holdings's Northwest Biotherapeutics, Inc. Common stock position peaked at $320K in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.